Daewoong Pharma
KRX:069620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Daewoong Pharma
KRX:069620
|
KR |
|
Y
|
Yunnan Coal & Energy Co Ltd
SSE:600792
|
CN |
|
Bank First Corp
F:42H
|
US |
|
C
|
Chugai Pharmaceutical Co Ltd
DUS:CUP
|
JP |
|
B
|
BYD Co Ltd
XHAM:BY6
|
CN |
|
Fairchem Organics Ltd
NSE:FAIRCHEMOR
|
IN |
|
B
|
Bechtle AG
XMUN:BC8
|
DE |
|
F
|
First Solar Inc
F:F3A
|
US |
|
Entera Bio Ltd
F:5DT
|
IL |
|
Viabuilt Ventures Inc
OTC:VBVT
|
US |
|
Woolworths Holdings Ltd
F:WN3
|
ZA |
|
I
|
Indika Energy Tbk PT
SWB:I41
|
ID |
Intrinsic Value
Is Daewoong Pharma undervalued or overvalued?
See the intrinsic value estimate for
Daewoong Pharma and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Daewoong Pharma Does
Daewoong Pharma is a South Korean drugmaker that develops, manufactures, and sells prescription medicines and other healthcare products. Its core business is making finished medicines that are used by hospitals, clinics, and pharmacies, along with some consumer health products sold over the counter. The company also works on pharmaceutical research and formulation, which helps it create and improve medicines for common medical needs.
- Headquarters
- Korea KR
- IPO date
- Nov 1, 2002
Revenue & Expenses Breakdown
Daewoong Pharma
Earnings Waterfall
Daewoong Pharma
The intrinsic value for
Daewoong Pharma (069620) under the Base Case is hidden KRW.
Compared with the current market price of 99 900 KRW, the stock appears hidden.